Silence Therapeutics | SLN - Spese Operative

Prezzo Delle Azioni
7.59
Cambio Giornaliero
-0.01 -0.13%
Mensile
9.84%
Annuale
141.72%
Q2 Previsione
5.62




Spese Operative Cambiamento Data
AstraZeneca USD 12.53B 4.16B 2025-12
Autolus Therapeutics Ltd USD 96.76M 3.94M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Novartis USD 9.8B 61M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Silence Therapeutics USD 12.5M 13.91M 2025-12